ERNA vs OKE · P/E 0.0, rev $582.0K vs P/E 15, rev $21.70B
Eterna Therapeutics Inc (ERNA) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the ERNA and OKE stock pages for the full models.
Not investment advice.